BetterScholar BetterScholar
Title Claps Level Year L/Y
CD19 expression is maintained in DLBCL patients after treatment with tafasitamab plus lenalidomide in the L-MIND study
9 auth. J. Duell, A. Obr, M. Augustin, J. Endell, Hao Liu, S. Geiger, ... I. Silverman, S. Ambarkhane, A. Rosenwald
Johannes Duell, Ale s Obr , Marinela Augustin, Jan Endell, Hao Liu, Sabine Geiger, Ian M. Silverman, Sumeet Ambarkhane and Andreas Rosenwald Medizinische Klinik und Poliklinik II, Universit€atsklinik W€ urzburg, W€urzburg, Germany; Department of Hem…
Johannes Duell, Ale s Obr , Marinela Augustin, Jan Endell, Hao Liu, Sabine Geiger, Ian M. Silverman, Sumeet Ambarkhane and Andreas Rosenwald Medizinische Klinik und Poliklinik II, Universit€atsklinik W€ urzburg, W€urzburg, Germany; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palack y University and University Hospital, Olomouc, Czech Republic; Klinik f€ur Innere Medizin 5, Universit€atsklinik der Paracelsus Medizinischen Privatuniversit€at, N€urnberg, Germany; MorphoSys AG, Planegg, Germany; Incyte Research Institute, Wilmington, DE, USA; Institute of Pathology, University of W€ urzburg, W€urzburg, Germany
Published in Leukemia and Lymphoma
0
3 2021